US Patent Issued to City of Hope on Oct. 20 for "Treatment of CNS lymphoma and systemic lymphoma with intracerebroventricularly administered CD19 car" (California Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,097, issued on Oct. 20, was assigned to City of Hope (Duarte, Calif.).

"Treatment of CNS lymphoma and systemic lymphoma with intracerebroventricularly administered CD19 car" was invented by Xiuli Wang (Temple City, Calif.) and Stephen J. Forman (Duarte, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An improved method of treating cancers CD19 CAR T cells by administering the CD19 CAR T cells to the central nervous system, e.g., by intracerebroventricular administration, is described."

The patent was filed on Nov. 7, 2018, under Application No. 16/762,225.

*For further information, including images, charts and tables, please visit: http://pa...